Ray Co

Ray Co EBIT per Share

The EBIT per Share of Ray Co (228670.KQ) as of Nov 18, 2026 is -627.33 KRW. In the previous year, EBIT per Share was -3,120.81 KRW — a change of -79.90% (higher).

EBIT per Share

-627.33KRW

YoY

-79.90%

Last updated:

EBIT per Share of Ray Co is 2025 -627.33 KRW. EBIT per Share of Ray Co was 2024 -3,120.81 KRW. It decreases by -79.90% higher compared to the previous year.

The Ray Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2021
81.10 KRW
Jan 1, 2022
1,156.42 KRW
Jan 1, 2023
120.12 KRW
Jan 1, 2024
-3,120.81 KRW
Jan 1, 2025
-627.33 KRW
Jan 1, 2026 (e)
1,067.83 KRW
Jan 1, 2027 (e)
1,423.46 KRW
Jan 1, 2028 (e)
1,614.92 KRW
The Ray Co EBIT per Share history
YEAREBIT per ShareYoY
est1,614.92KRW+13.45%
est1,423.46KRW+33.30%
est1,067.83KRW-270.22%
-627.33KRW-79.90%
-3,120.81KRW-2,698.16%
120.12KRW-89.61%
1,156.42KRW+1,325.85%
81.10KRW-76.44%
344.24KRW-64.38%
966.52KRW+79.73%
537.75KRW+195.13%
182.21KRW+46.87%
124.06KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ray Co Stock analysis

What does Ray Co do? Ray Co., Ltd. generates revenue through the manufacturing and sale of advanced technology medical devices, focusing on digital diagnostic systems and digital therapy solutions. The company produces dental radiography equipment such as x-ray systems and cone beam computed tomography (CBCT) systems, alongside 3D scanning, dental computer aided design (CAD), and 3D printers for prosthodontics, orthodontics, and implant surgery. Domestic and overseas markets purchase these products, with the company operating through subsidiaries to distribute its offerings globally. Digital diagnostic systems like dental radiography equipment and CBCT systems are sold to healthcare providers and dental clinics, while digital therapy solutions including 3D scanning and CAD systems target dental laboratories and surgical centers. The firm's product portfolio serves both domestic and international clients, leveraging its subsidiaries for global distribution channels. Ray Co., Ltd. emphasizes advanced technology in its medical device offerings, with digital therapy solutions such as 3D printers and CAD systems being key revenue drivers. The company's focus on dental-specific applications ensures targeted sales to specialized healthcare segments, including prosthodontics, orthodontics, and implant surgery practices. Ray Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ray Co stock

EBIT per Share of Ray Co is -627.33 KRW in 2025.

EBIT per Share of Ray Co changed from -3,120.81 KRW to -627.33 KRW, representing a -79.90% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Ray Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Ray Co

All Key Metrics — Ray Co